Fulvestrant Patents

Given below is the list of patents protecting Fulvestrant, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Fulvestrant's patents.

Latest Legal Activities on Fulvestrant's Patents

Given below is the list recent legal activities going on the following patents of Fulvestrant.

Activity	Date	Patent Number
Critical Events This Week
Payment of Maintenance Fee, 8th Year, Large Entity	05 Jun, 2025	US9833459
Payment of Maintenance Fee, 8th Year, Large Entity	01 Sep, 2023	US9271990
Payment of Maintenance Fee, 4th Year, Large Entity	29 Jul, 2022	US10188663
Payment of Maintenance Fee, 4th Year, Large Entity	07 Jun, 2021	US9833459
Payment of Maintenance Fee, 4th Year, Large Entity	03 Sep, 2019	US9271990
Recordation of Patent Grant Mailed Critical	29 Jan, 2019	US10188663
Patent Issue Date Used in PTA Calculation Critical	29 Jan, 2019	US10188663
Email Notification Critical	10 Jan, 2019	US10188663
Issue Notification Mailed Critical	09 Jan, 2019	US10188663
Application Is Considered Ready for Issue Critical	20 Dec, 2018	US10188663